Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/19/16 → 12/6/18 |
Funding
- Xcovery Holding Company LLC: $10,406.25
A Phase I, First-In-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of X-396 in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphoma
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research